Spojené státy - angličtina - NLM (National Library of Medicine)

reviresco co., ltd. - tranexamic acid (unii: 6t84r30kc1) (tranexamic acid - unii:6t84r30kc1), adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567) - purpose: anti wrinkle uses: for anti-wrinkle

Spojené státy - angličtina - NLM (National Library of Medicine)

e.l.f. cosmetics, inc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - - for the treatment of acne - helps prevent new acne blemishes - for the treatment of acne - helps prevent new acne blemishes

Spojené státy - angličtina - NLM (National Library of Medicine)

e.l.f. cosmetics, inc. - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - - for the treatment of acne - helps prevent new acne blemishes

Spojené státy - angličtina - NLM (National Library of Medicine)

e.l.f. cosmetics, inc. - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - - for the treatment of acne - helps prevent new acne blemishes

Spojené státy - angličtina - NLM (National Library of Medicine)

e.l.f. cosmetics, inc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - - for the treatment of acne  - helps prevent new acne blemishes

Spojené státy - angličtina - NLM (National Library of Medicine)

oxygen development llc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - acne medication treats acne and helps skin heal. penetrates pores to eliminate most acne blemishes and blackheads. helps prevent new acne blemishes and blackheads from forming using other topical acne medications at the same time or immediately following use of this product may increase dryness or irritation of the skin. if this occurs, only one medication should be used unless directed by a doctor.

Spojené státy - angličtina - NLM (National Library of Medicine)

shantou youjia e-commerce co., ltd. - arbutin (unii: c5ina23hxf) (arbutin - unii:c5ina23hxf), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), glycerin (unii: pdc6a3c0ox) (glycerin - unii:pdc6a3c0ox), hyaluronic acid (unii: s270n0trqy) (hyaluronic acid - unii:s270n0trqy), tranexamic acid (unii: 6t84r30kc1) (tranexamic acid - unii:6t84r30kc1) -

Spojené státy - angličtina - NLM (National Library of Medicine)

bentley laboratories, llc - titanium dioxide (unii: 15fix9v2jp) (titanium dioxide - unii:15fix9v2jp), zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - titanium dioxide 0.38400 g in 4 g - sunscreen - helps prevent sunburn on damaged or broken skin if rash occurs

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

medsurge pharma limited - tranexamic acid 100 mg/ml;   - solution for injection - 500 mg/5ml - active: tranexamic acid 100 mg/ml   excipient: hydrochloric acid sodium hydroxide water for injection - haemorrhage or risk of haemorrhage in increased fibrinolysis or fibrinogenolysis. local fibrinolysis may occur in the following conditions: - prostatectomy and bladder surgery - menorrhagia - epistaxis - conisation of the cervix - management of dental extraction in patients with coagulopathies - ulcerative colitis - haematuria (tranexamic acid therapy is not indicated in haematuria caused by diseases of the renal parenchyma (also see precautions). - gastrointestinal haemorrhage.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

boucher & muir (nz) ltd t/a mercury pharma (nz) - tranexamic acid 500mg - film coated tablet - 500 mg - active: tranexamic acid 500mg excipient: basic butylated methacrylate copolymer colloidal silicon dioxide croscarmellose sodium isopropyl alcohol macrogol 8000 magnesium stearate   microcrystalline cellulose povidone purified talc   purified water titanium dioxide vanillin - haemorrhage or risk of haemorrhage in increased fibrinolysis or fibrinogenolysis. local fibrinolysis may occur in the following conditions: -prostatectomy and bladder surgery -menorrhagia -epistaxis -conisation of the cervix - management of dental extraction in patients with coagulopathies - ulcerative colitis - haematuria (tranexamic acid therapy is not indicated in haematuria caused by diseases of the renal parenchyma) -gastrointestinal haemorrhage general fibrinolysis as in prostatic and pancreatic cancer; after thoracic and other major surgery: - in obstetrical complications such as abruptio placentae and post-partum haemorrhage - in leukaemia and liver diseases and in connection with thrombolytic therapy with streptokinase hereditary angioneurotic oedema. for the reduction of peri– and post-operative blood loss and the need for blood transfusion in adult patients undergoing cardiac surgery or total knee arthroplasty or total hip arthroplasty. for the reduction of peri- and post-operative blood loss and the need for blood transfusion in paediatric patients undergoing cardiac surgery.